Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (ZNTL)

Q: What does CUSIP 98943L107 represent in this 13F holders report?

CUSIP 98943L107 is the security identifier for ZNTL - Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share used to aggregate holder disclosures.

Q: How many institutions held ZNTL - Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share in Q2 2021?

117 institutional investors reported ZNTL - Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share for Q2 2021. Use the holders table for investor-level position and value details.

CUSIP: 98943L107

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / Common Stock,$0.001 par value per share
Shares outstanding: 72,096,078
Total 13F shares: 39,699,603
Share change: +3,734,870
Total reported value: $2,112,018,735
Put/Call ratio: 19%
Price per share: $53.20
Number of holders: 117
Value change: +$205,833,024
Number of buys: 88
Number of sells: 28

Quarterly Holders Quick Answers

What is CUSIP 98943L107?
CUSIP 98943L107 identifies ZNTL - Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 98943L107:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ZNTL - Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	8.5%	6,156,042	$267,111,000	—	31 Mar 2021	13F
Matrix Capital Management Company, LP	13F	Company	5.3%	3,821,739	$165,825,000	—	31 Mar 2021	13F
TYBOURNE CAPITAL MANAGEMENT (HK) LTD	13F	Company	3.7%	2,664,409	$115,609,000	—	31 Mar 2021	13F
VANGUARD GROUP INC	13F	Company	3.4%	2,418,848	$104,954,000	—	31 Mar 2021	13F
VIKING GLOBAL INVESTORS LP	13F	Company	3.3%	2,399,284	$104,105,000	—	31 Mar 2021	13F
BlackRock Finance, Inc.	13F	Company	3.2%	2,276,773	$98,789,000	—	31 Mar 2021	13F
Redmile Group, LLC	13F	Company	3.1%	2,221,044	$96,371,000	—	31 Mar 2021	13F
STATE STREET CORP	13F	Company	2%	1,469,191	$63,748,000	—	31 Mar 2021	13F
FEDERATED HERMES, INC.	13F	Company	1.9%	1,404,339	$60,934,000	—	31 Mar 2021	13F
PRIMECAP MANAGEMENT CO/CA/	13F	Company	1.9%	1,335,430	$57,944,000	—	31 Mar 2021	13F
Avidity Partners Management LP	13F	Company	1.8%	1,263,300	$54,815,000	—	31 Mar 2021	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	1.5%	1,105,282	$47,958,000	—	31 Mar 2021	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	1.5%	1,084,246	$47,045,000	—	31 Mar 2021	13F
CITADEL ADVISORS LLC	13F	Company	1.5%	1,055,389	$45,794,000	—	31 Mar 2021	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	1.2%	832,000	$36,100,000	—	31 Mar 2021	13F
Polar Capital Holdings Plc	13F	Company	0.62%	450,000	$19,526,000	—	31 Mar 2021	13F
Capital World Investors	13F	Company	0.51%	370,000	$16,054,000	—	31 Mar 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.51%	366,840	$15,917,000	—	31 Mar 2021	13F
Mayo Clinic	13F	Company	0.5%	362,459	$15,727,096	—	31 Mar 2021	13F
FRANKLIN RESOURCES INC	13F	Company	0.45%	327,197	$14,197,000	—	31 Mar 2021	13F
NORTHERN TRUST CORP	13F	Company	0.39%	283,313	$12,293,000	—	31 Mar 2021	13F
Invesco Ltd.	13F	Company	0.32%	233,007	$10,110,000	—	31 Mar 2021	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.24%	175,140	$7,599,000	—	31 Mar 2021	13F
AXA S.A.	13F	Company	0.23%	164,012	$7,116,000	—	31 Mar 2021	13F
Woodline Partners LP	13F	Company	0.2%	144,161	$6,255,000	—	31 Mar 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.18%	128,845	$5,591,000	—	31 Mar 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.18%	128,229	$5,564,000	—	31 Mar 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.16%	116,900	$5,072,000	—	31 Mar 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.13%	90,542	$3,929,000	—	31 Mar 2021	13F
Bank of New York Mellon Corp	13F	Company	0.12%	89,801	$3,897,000	—	31 Mar 2021	13F
CITIGROUP INC	13F	Company	0.11%	82,372	$3,574,000	—	31 Mar 2021	13F
Affinity Asset Advisors, LLC	13F	Company	0.11%	77,500	$3,363,000	—	31 Mar 2021	13F
Rafferty Asset Management, LLC	13F	Company	0.09%	65,526	$2,843,000	—	31 Mar 2021	13F
Verition Fund Management LLC	13F	Company	0.09%	64,718	$2,808,000	—	31 Mar 2021	13F
GAMCO INVESTORS, INC. ET AL	13F	Company	0.09%	62,711	$2,721,000	—	31 Mar 2021	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.08%	58,256	$2,528,000	—	31 Mar 2021	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	0.08%	56,776	$2,464,000	—	31 Mar 2021	13F
MORGAN STANLEY	13F	Company	0.07%	53,069	$2,303,000	—	31 Mar 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.07%	51,809	$2,248,000	—	31 Mar 2021	13F
Pentwater Capital Management LP	13F	Company	0.06%	45,000	$1,953,000	—	31 Mar 2021	13F
MOORE CAPITAL MANAGEMENT, LP	13F	Company	0.06%	44,993	$1,952,000	—	31 Mar 2021	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.06%	43,349	$1,881,000	—	31 Mar 2021	13F
Swiss National Bank	13F	Company	0.06%	41,800	$1,814,000	—	31 Mar 2021	13F
Graticule Asia Macro Advisors LLC	13F	Company	0.06%	41,550	$1,803,000	—	31 Mar 2021	13F
Integral Health Asset Management, LLC	13F	Company	0.06%	40,000	$1,736,000	—	31 Mar 2021	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.05%	38,700	$1,679,000	—	31 Mar 2021	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.05%	37,000	$1,605,000	—	31 Mar 2021	13F
RHUMBLINE ADVISERS	13F	Company	0.04%	30,609	$1,328,000	—	31 Mar 2021	13F
TD ASSET MANAGEMENT INC	13F	Company	0.04%	29,215	$1,268,000	—	31 Mar 2021	13F
NORGES BANK	13F	Company	0.04%	28,926	$1,255,000	—	31 Mar 2021	13F

Institutional Holders of Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (ZNTL) as of Q2 2021

As of 30 Jun 2021, Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (ZNTL) was held by 117 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 39,699,603 shares. The largest 10 holders included FMR LLC, Matrix Capital Management Company, LP, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, TYBOURNE CAPITAL MANAGEMENT (HK) LTD, VIKING GLOBAL INVESTORS LP, BlackRock Inc., Avidity Partners Management LP, PRIMECAP MANAGEMENT CO/CA/, and STATE STREET CORP. This page lists 117 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

Q2 2021 holders

117

Holder diff

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 Value $	Q2 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.